CD163 and central nervous system cancer: Intratumoral CD68+ (P = 0.0029), CD11c+CD68+ (P = 0.0018) and CD11c+CD68+CD163+ (P = 0.0029) cells were more likely to express p-STAT3 in gliomas (Figure 3B).